JSKN003 targets HER2 epitopes, releasing topoisomerase I inhibitors, providing selective antitumor activity with reduced hematological toxicity in PROC. Fast track designation allows Alphamab Oncology ...
Therapeutic advances across the gynecologic cancer continuum have resulted in improvements in patient care and outcomes over the past decade, yet challenges remain. In ovarian cancer, the evolution of ...
"The interim results demonstrated a highly differentiated clinical profile for TUB-040 in the ADC field, with anti-tumor activity beginning at low doses with a broad therapeutic window that could ...
A new SQL Server 2025 feature lets organizations run vector-based semantic searches on their own data, connecting to local or cloud-hosted AI models without relying on massive general-purpose LLMs. I ...
The House began voting July 2, 2025, on whether to open debate for a sprawling Trump-backed domestic spending bill, but some GOP holdouts could endanger its passage. With such close margins, a tie ...
Phase 2, multicenter study of frontline maintenance therapy with lifileucel plus pembrolizumab in advanced non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
Organizations are using generative AI to stay ahead of the competition, but the real advantage lies in harnessing the power of your own data securely and at scale. One of the most exciting new ...
In announcing SQL Server Management Studio (SSMS) 21 Preview 1 this week, Microsoft revealed Copilot AI for the tool is also being previewed, privately. A Copilot for the tool that helps users manage, ...
When The Pew Charitable Trusts created Pew Research Center in 2004, we were surveying Americans using the established industry method at the time: calling people on their landline phones and hoping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results